Today, September 24th, is #WorldCancerResearchDay. It is a yearly momentum to raise awareness and commitment for cancer research. This day also serves as a reminder that progress depends on collaboration.

Hugely excited to meet the @mac4me.bsky.social team in Rotterdam for our kick-off meeting. Here with @peptimatrix.bsky.social and a whole interdisciplinary team ’opening new doors in cancer immunotherapy’ www.mac4me.eu

The @mac4me.bsky.social project officially kicked off in Rotterdam on 25-26 June! It was great to connect with partners in person and meet our DC, Elena Montero Bragado. 🔗 Read the Full story: www.peptimatrix.com/post/mac4me-... #Mac4Me #HorizonEurope #CancerResearch #3DCellCulture #MSCA

🎊 The Mac4Me Doctoral Network officially kicked off two weeks ago (25-26 June)! 🎉 Our core partners gathered to set the stage for four years of research. We're excited for what's ahead!

On European Patients' Rights Day, we remember that patients deserve effective treatment and clear information. Mac4Me's research aims to personalise immunotherapies for metastatic cancers, better predict treatment outcomes and keep people informed all the way through. Learn more at mac4me.eu

On this #WomensDay, we recognise the impact of breast cancer on women around the world. Today, we remark the dedication of female researchers who are advancing metastasis understanding and the vital role of women's perspectives in shaping more effective and inclusive cancer care and research.

🎉 Yesterday we launched online Mac4Me - an European doctoral network studying Macrophage Targets for Metastatic Treatment! We are investigating neuroblastoma, breast, and prostate cancers - three tumor types that share metastatic spread to brain, bone, and liver.